Atlas Trials

Dopamine D2 Receptors(D2R) Imaging in Prolactinomas

Clinical trial NCT03717454 · UNKNOWN

Trial details

NCT number
NCT03717454
Sponsor
Zhebao Wu
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Prolactinoma
Start date
2018-12-01
Primary completion
2021-12-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.